• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [520 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cetuximab (Erbitux) in EGFR-expressing Non-Small Cell Lung Cancer
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Minimal access lobectomy for lung cancer patients: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost-effectiveness
2009 National Institute for Health and Care Excellence (NICE) Topotecan for the treatment of relapsed small-cell lung cancer. NICE technology appraisal guidance 184
2009 National Institute for Health and Care Excellence (NICE) Pemetrexed for the first-line treatment of non-small-cell lung cancer. NICE technology appraisal guidance 181
2009 Committee for New Health Technology Assessment (CNHTA) [Radiofrequency (RF) ablation of primary and secondary lung malignancy]
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical- and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumors of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost effectiveness
2009 NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF-Trap) for locally advanced or metastatic non-small cell lung cancer - second line
2009 HAYES, Inc. Positron emission tomography (PET) for diagnosing and staging lung cancer
2009 HAYES, Inc. Positron emission tomography (PET) for treatment planning of lung cancer
2009 Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2009 NIHR Health Technology Assessment programme Erlotinib for the treatment of relapsed non-small cell lung cancer
2009 HAYES, Inc. Combined positron emission tomography-computed tomography (PET-CT) for lung
2009 Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2009 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Lung cancer screening]
2009 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [New treatment with avastin and alimta for patients with non-small cell lung cancer]
2008 Adelaide Health Technology Assessment (AHTA) Screening for lung cancer utilising computer tomography (CT)
2008 National Institute for Health and Care Excellence (NICE) Endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal masses. NICE interventional procedures guidance 254
2008 VA Technology Assessment Program (VATAP) Electromagnetic navigation bronchoscopy
2008 HAYES, Inc. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of mediastinal lymph nodes in patients with lung cancer
2008 National Institute for Health and Care Excellence (NICE) Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal). NICE technology appraisal guidance 148
2008 NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium (Alimta) monotherapy as maintenance therapy for non-small cell lung cancer
2008 Canadian Agency for Drugs and Technologies in Health (CADTH) Cryotherapy for non-small cell lung cancer: a review of the clinical effectiveness
2008 NIHR Horizon Scanning Centre (NIHR HSC) Picoplatin for small cell lung cancer - second line
2008 The Netherlands Organisation for Health Research and Development (ZonMw) [Diagnosis and staging of lung cancer by endoscopic ultrasound guided fine needle aspiration (EUS-FNA)]
2008 NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) for non small cell lung cancer advanced or metastatic-maintenance monotherapy
2008 NIHR Horizon Scanning Centre (NIHR HSC) Amrubicin for small cell lung cancer - relapsed and/or refractory, extensive disease
2008 Medical Services Advisory Committee (MSAC) Endobronchial ultrasound in the staging of lung cancer and the diagnosis of mediastinal masses of unknown origin
2008 HAYES, Inc. Epidermal growth factor receptor (EGFR) gene amplification analysis by fluorescence in situ hybridization (FISH) for predicting response to non-small cell lung cancer (NSCLC) drug therapy
2008 HAYES, Inc. Epidermal growth factor receptor (EGFR) sequence variant analysis for predicting response to non-small cell lung cancer (NSCLC) drug therapy
2008 HAYES, Inc. KRAS sequence variant analysis for non-small cell lung cancer (NSCLC)
2008 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Intravenous topotecan (Hycamtin®)
2008 HAYES, Inc. Radiofrequency ablation (RFA) of malignant pulmonary tumors in nonsurgical candidates
2008 HAYES, Inc. CyberKnife robotic radiosurgery system (Accuray Inc.) for lung cancer and other non-neurological indications
2008 NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium (Alimta) monotherapy as maintenance therapy for non-small cell lung cancer
2008 Agency for Healthcare Research and Quality (AHRQ) Positron emission tomography for nine cancers (bladder, brain, cervical, kidney, ovarian, pancreatic, prostate, small cell lung, testicular)
2007 NIHR Horizon Scanning Centre (NIHR HSC) Lungscreen for lung cancer detection in high-risk patients: horizon scanning technology briefing
2007 Blue Cross Blue Shield Association (BCBS) Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer
2007 Andalusian Health Technology Assessment Area (AETSA) [Selective screening for lung cancer with chest CT]
2007 Blue Cross Blue Shield Association (BCBS) Off-label uses of Sorafenib and Sunitinib
2007 National Institute for Health and Care Excellence (NICE) Pemetrexed for the treatment of non-small-cell lung cancer. NICE technology appraisal guidance 124
2007 NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) in combination with bevacizumab for advanced or metastatic non-small cell lung cancer
2007 NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for advanced non-small cell lung cancer
2007 NIHR Horizon Scanning Centre (NIHR HSC) Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer
2007 Medical Services Advisory Committee (MSAC) Endoscopic ultrasound and fine needle aspiration for lung cancer
2007 HAYES, Inc. Bevacizumab (Avastin) for non-small cell lung cancer
2007 Quality Improvement Scotland (NHS QIS ) Pemetrexed for the treatment of non-small-cell lung cancer
2007 Adelaide Health Technology Assessment (AHTA) Screening for lung cancer utilising computed tomography
2006 HAYES, Inc. Helical tomotherapy (TomoTherapy Hi-Art System) for non-small cell lung cancer (NSCLC)
2006 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews
2006 NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) for Non-Small Cell Lung Cancer: horizon scanning technology briefing
2006 NIHR Health Technology Assessment programme Pemetrexed for the treatment of relapsed non-small cell lung cancer
2006 Blue Cross Blue Shield Association (BCBS) Off-label uses of Bevacizumab: breast and lung cancer indications
2006 Agency for Healthcare Research and Quality (AHRQ) Management of small cell lung cancer
2006 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Electromagnetic navigation (SuperDimension/Bronchus(R)) and echo-endoscopy for the diagnosis of peripheral and mediastinal lesions - systematic review, expert panel
2006 HAYES, Inc. Conformal radiation therapy for lung cancer
2006 Canadian Agency for Drugs and Technologies in Health (CADTH) CT and MRI for selected clinical disorders: a systematic review of economic evaluations
2006 Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical and cost effectiveness of CT and MRI for selected clinical disorders: results of two systematic reviews
2006 HAYES, Inc. Neutron beam therapy for lung cancer
2006 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) 18-FDG positron emission tomography for non-small cell lung cancer: cost-effectiveness reports
2006 Blue Cross Blue Shield Association (BCBS) Special report: intensity-modulated radiation therapy for cancer of the breast or lung
2006 Adelaide Health Technology Assessment (AHTA) Epidermal growth factor receptor mutational assay for patients with non small-cell lung carcinoma
2005 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) CT and MRI for selected clinical disorders: a systematic review of clinical systematic reviews
2005 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for non-small cell lung cancer (NSCLC) - horizon scanning review
2005 Institute for Clinical Effectiveness and Health Policy (IECS) Gefitinib for advanced lung cancer treatment
2005 Institute for Clinical Effectiveness and Health Policy (IECS) Erlotinib for the management of advanced lung cancer
2005 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health technology assessment of erlotnib (Tarceva) for palliative treatment of non-small cell lung cancer]
2005 Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Prophylactic antibiotics vs prophylactic G-CSF in prevention of febrile neuropenia in patients with a small cell bronchus carcinoma - primary research
2005 National Institute for Health and Care Excellence (NICE) Cryotherapy for malignant endobronchial obstruction. NICE interventional procedures guidance 142
2005 National Institute for Health and Care Excellence (NICE) Photodynamic therapy for localised inoperable endobronchial cancer. NICE interventional procedures guidance 137
2005 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) 18-FDG positron emission tomography for non-small cell lung cancer
2005 Health Council of the Netherlands Gezondheidsraad (GR) Asbestos diseases: lung cancer
2005 Agency for Healthcare Research and Quality (AHRQ) Relative efficacy of oral cancer therapy for Medicare beneficiaries versus currently covered therapy: part 1, gefitinib and erlotinib for non-small cell lung cancer
2004 NIHR Horizon Scanning Centre (NIHR HSC) Breath test for lung cancer screening - horizon scanning review
2004 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Assessment of photodynamic therapy using porfimer sodium for esophageal, bladder and lung cancers
2004 Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Irradiation of the bronchuscarcinoma - primary research
2004 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Gefitinib for inoperable or recurrent non-small cell lung cancer
2004 National Institute for Health and Care Excellence (NICE) Photodynamic therapy for advanced bronchial carcinoma. NICE interventional procedures guidance 87
2004 Agency for Healthcare Research and Quality (AHRQ) Positron emission testing for six cancers (brain, cervical, small cell lung, ovarian, pancreatic and testicular)
2004 Adelaide Health Technology Assessment (AHTA) ImageChecker CT-LN: a computer-aided system for the detection of lung cancer nodules
2004 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Gefitinib for advanced or metastatic non-small cell lung cancer
2004 Adelaide Health Technology Assessment (AHTA) Breath test for lung cancer detection in high-risk patients
2004 Agency for Healthcare Research and Quality (AHRQ) Lung cancer screening: an update for the U.S. Preventive Services Task Force
2003 Institute for Clinical Evaluative Sciences (ICES) Health technology assessment of positron emission tomography in oncology - a systematic review
2003 Institute for Clinical Evaluative Sciences (ICES) Health technology assessment of positron emission tomography in oncology - a systematic review
2003 NIHR Horizon Scanning Centre (NIHR HSC) BEC-2 for small cell lung cancer - horizon scanning review
2003 NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib for pancreatic and non-small cell lung cancer - horizon scanning review
2003 NIHR Horizon Scanning Centre (NIHR HSC) ISIS 3521 for non small cell lung cancer - horizon scanning review
2003 The Swedish Council on Health Technology Assessment (SBU) Computed tomography in screening for lung cancer. Version 2.0 - early assessment briefs (Alert)
2003 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Lung OncoGuide
2003 HAYES, Inc. Helical computed tomography for lung cancer screening
2003 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Multi-slice/helical computed tomography for lung cancer screening
2003 Canadian Task Force on Preventive Health Care (CTFPHC) Screening for lung cancer: updated recommendations from the Canadian Task Force on Preventive Health Care
2002 NIHR Horizon Scanning Centre (NIHR HSC) Tirapazamine for non-small cell lung cancer - horizon scanning review
2002 HAYES, Inc. Positron emission tomography (PET) for lung cancer
2002 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Treatment of inoperable advanced non-small-cell lung cancer: regimens with or without taxane
2002 NIHR Horizon Scanning Centre (NIHR HSC) Iressa for NSCLC - horizon scanning review
2002 NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium for mesothelioma and NSCLC - horizon scanning review